CKD impairs barrier function and alters microbial flora of the intestine: a major link to inflammation and uremic toxicity.
about
Gut microbes and host physiology: what happens when you host billions of guests?Stop chronic kidney disease progression: Time is approachingHigh Fat High Cholesterol Diet (Western Diet) Aggravates Atherosclerosis, Hyperglycemia and Renal Failure in Nephrectomized LDL Receptor Knockout Mice: Role of Intestine Derived LipopolysaccharideExpansion of urease- and uricase-containing, indole- and p-cresol-forming and contraction of short-chain fatty acid-producing intestinal microbiota in ESRD.Microbiota and metabolome associated with immunoglobulin A nephropathy (IgAN).Alteration of the gut microbiota in Chinese population with chronic kidney diseaseEffect of increasing dietary fiber on plasma levels of colon-derived solutes in hemodialysis patientsHigh amylose resistant starch diet ameliorates oxidative stress, inflammation, and progression of chronic kidney diseaseIron-ascorbate-mediated lipid peroxidation causes epigenetic changes in the antioxidant defense in intestinal epithelial cells: impact on inflammationDietary protein metabolism by gut microbiota and its consequences for chronic kidney disease patients.Role of altered intestinal microbiota in systemic inflammation and cardiovascular disease in chronic kidney disease.Alterations of intestinal barrier and microbiota in chronic kidney disease.Alteration of the Intestinal Environment by Lubiprostone Is Associated with Amelioration of Adenine-Induced CKD.Comparative pharmacokinetics of catalpol and acteoside in normal and chronic kidney disease rats after oral administration of Rehmannia glutinosa extract.Gut-Microbiota-Metabolite Axis in Early Renal Function Decline.Effect of microbial cell preparation on renal profile and liver function among type 2 diabetics: a randomized controlled trial.A reduction in the butyrate producing species Roseburia spp. and Faecalibacterium prausnitzii is associated with chronic kidney disease progression.Is Endotoxemia in Stable Hemodialysis Patients an Artefact? Limitations of the Limulus Amebocyte Lysate Assay and Role of (1→3)-β-D Glucan.Identification of biomarkers for development of end-stage kidney disease in chronic kidney disease by metabolomic profilingEvidence of perturbed germinal center dynamics, but preserved antibody diversity, in end-stage renal disease.Role of urea in intestinal barrier dysfunction and disruption of epithelial tight junction in chronic kidney disease.Uremic plasma impairs barrier function and depletes the tight junction protein constituents of intestinal epithelium.Risk factors influencing the outcome of peptic ulcer bleeding in chronic kidney disease after initial endoscopic hemostasis: A nationwide cohort study.Intestinal microbiota in pediatric patients with end stage renal disease: a Midwest Pediatric Nephrology Consortium studyThe effects of acute renal failure on drug metabolism.From microbe to man: the role of microbial short chain fatty acid metabolites in host cell biology.Curcumin and chronic kidney disease (CKD): major mode of action through stimulating endogenous intestinal alkaline phosphatase.Gut microbiota and chronic kidney disease: implications for novel mechanistic insights and therapeutic strategies.Could physical exercise help modulate the gut microbiota in chronic kidney disease?Gut microbiota in renal physiology: focus on short-chain fatty acids and their receptors.The gut-kidney axis.Asymptomatic Effluent Protozoa Colonization in Peritoneal Dialysis Patients.Measurement of the intestinal permeability in chronic kidney disease.A novel SCFA receptor, the microbiota, and blood pressure regulation.Gut microbiota and inflammation in chronic kidney disease patients.Oral activated charcoal adsorbent (AST-120) ameliorates chronic kidney disease-induced intestinal epithelial barrier disruptionCutting Edge Methods for Non-Invasive Disease Diagnosis Using E-Tongue and E-Nose Devices.Gut microbial translocation in the pathogenesis of systemic inflammation in patients with end-stage renal disease.Effects of end-stage renal disease and dialysis modalities on blood ammonia level.Gut Lactobacillus protects against the progression of renal damage by modulating the gut environment in rats.
P2860
Q26822836-A47078B8-D75F-4940-AFAA-43CA79C0C042Q28078020-31577FFA-DBC9-45C6-988C-95A51C7F44E3Q28551030-4B6DA637-D0F2-494E-ADCC-FE88344BA4A6Q33725646-7DB3B2FE-6349-4F8B-832C-79C275AAA7B1Q33748498-177CE78B-BB46-4BB7-936C-FE65D82DFE7CQ33767631-AF5ED4C3-1327-4564-B850-BA78D6551DBEQ34124697-7ECE1277-984F-479E-AB3E-BD35437132BDQ34663426-BAFB65A9-0082-4102-93F7-E3B0226EBDF1Q34744111-6F9D5064-1ABA-4FF5-8904-1334F81A9F59Q34995574-F002C376-DC13-49D8-ACED-F3AD5F365879Q35156688-B53B25F6-A67A-44E3-8B82-667AF5440B38Q35239148-7478A616-87DF-4E9C-9650-D3A3B46DDAC0Q35530569-BC48EA56-CCAB-42DA-A00C-D159E505F27FQ35648605-35133581-3C42-4F01-8725-0634A83E7F63Q35737363-329B5B37-A285-4A1D-91BE-FB1D306232C1Q35865699-FF26C814-E8DB-419F-B4AD-74F0FF7DE951Q36081100-12CA1FEF-648C-4898-B171-1CA10B9BAD23Q36169427-EDED2FC5-13D1-4A0E-8284-ED9F54A72C9AQ36910790-2505616A-A67E-46F3-BFE3-3D0E3AA0CA6AQ36933665-4BE8F0A4-639D-4ADB-86B6-3BC59770D411Q36940342-C4F09472-411E-487D-BF5C-FCF599093217Q37050237-2AB2C1EA-D5AD-4F6A-A878-0650994D3876Q37257016-A68A9CC0-43B3-403C-8BF1-FBD87AFF73B4Q37263314-EA81FC49-2A14-44FA-A1FC-A2D57C9457D5Q38145416-E19F0F83-53D8-4263-88FF-004A40179004Q38255944-5DB35382-B8BA-41CD-99DD-B53F1C7AD034Q38283016-E86BA6CA-EE82-438A-B3A7-E1DA6AC287D0Q38636372-261DEA02-58A1-40EC-8ABB-BDA870AB21B5Q38829608-F3A21B61-E075-4FEF-B53B-1B0F64123AD4Q38941009-DAB515B9-60A5-45B4-BFFA-33168B6B81AAQ39009765-54DA1D80-00DF-4565-8B76-07EB8F0151D5Q40530031-9545BB0F-CA33-4630-8BE5-B3E927DA72C4Q40599724-237A7AF6-69DF-4DF2-9248-98D18C11B434Q40899577-9E8D6629-3E9F-4689-B0FA-297C8016205BQ40940672-04EBB109-53BD-47E4-9AF1-78850F606C25Q42042998-DCB65972-F7B6-4616-82DF-B2E9733A353EQ45305943-3873B367-283A-4289-8A3B-1B6894F2AD63Q46272282-E8856E5C-F98D-4B80-80D0-F153421D582AQ46632759-84514FCF-8457-4177-A51C-F1FE9389DFDBQ46650965-2AEA2131-E28B-4CCF-BB9C-EF84AA2B81EE
P2860
CKD impairs barrier function and alters microbial flora of the intestine: a major link to inflammation and uremic toxicity.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
CKD impairs barrier function a ...... lammation and uremic toxicity.
@en
CKD impairs barrier function a ...... lammation and uremic toxicity.
@nl
type
label
CKD impairs barrier function a ...... lammation and uremic toxicity.
@en
CKD impairs barrier function a ...... lammation and uremic toxicity.
@nl
prefLabel
CKD impairs barrier function a ...... lammation and uremic toxicity.
@en
CKD impairs barrier function a ...... lammation and uremic toxicity.
@nl
P2860
P1476
CKD impairs barrier function a ...... lammation and uremic toxicity.
@en
P2093
Nosratola D Vaziri
P2860
P304
P356
10.1097/MNH.0B013E328358C8D5
P577
2012-11-01T00:00:00Z